1
40
6
-
Text
A resource consisting primarily of words for reading. Examples include books, letters, dissertations, poems, newspapers, articles, archives of mailing lists. Note that facsimiles or images of texts are still of the genre Text.
URL Address
<a href="http://doi.org/10.1046/j.1525-1438.2001.01011.x" target="_blank" rel="noreferrer noopener">http://doi.org/10.1046/j.1525-1438.2001.01011.x</a>
Rights
Article information provided for research and reference use only. All rights are retained by the journal listed under publisher and/or the creator(s).
Pages
205-209
Issue
3
Volume
11
Search for Full-text
Locate full-text within NEOMED Library's e-journal collections
<p>Users with a NEOMED Library login can search for full-text journal articles at the following url: <a href="https://libraryguides.neomed.edu/home">https://libraryguides.neomed.edu/home</a></p>
Dublin Core
The Dublin Core metadata element set is common to all Omeka records, including items, files, and collections. For more information see, http://dublincore.org/documents/dces/.
Title
A name given to the resource
A comparison of complementary and alternative medicine use by gynecology and gynecologic oncology patients
Publisher
An entity responsible for making the resource available
International Journal of Gynecological Cancer
Date
A point or period of time associated with an event in the lifecycle of the resource
2001
2001-05
Subject
The topic of the resource
cancer patients; complementary and alternative medicines; gynecological oncology; gynecology; Obstetrics & Gynecology; Oncology; prevalence; therapies; united-states
Creator
An entity primarily responsible for making the resource
Von Gruenigen V E; White L J; Kirven M S; Showalter A L; Hopkins M P; Jenison E L
Description
An account of the resource
Our objective was to describe and compare the use of complementary and alternative medicine (CAM) in gynecology and gynecological oncology patients. Five hundred and twenty-nine gynecology and gynecological oncology patients completed a questionnaire regarding: CAM use. Overall, 56.3% of gynecology and gynecological oncology patients reported current use of CAM. Therapies used included nutritional supplements (20%), prayer as medical therapy (17%), exercise as medical therapy (12%), megavitamins (10%), and green tea (10%). While 69.5% believed CAM to be beneficial, only 31.6% discussed these therapies with their physician. The women spent a mean of $656.22 on CAM (range $0-$7,000), with 31.7% receiving some insurance reimbursement. Gynecologic oncology patients (n=161) used CAM significantly more than gynecology patients (n=368) (66% vs. 52%, 95% CI=0.046-0.230, P=0.004). Gynecological oncology patients also spent more for CAM, with a mean expenditure of $711 versus $622 by gynecology patients. Within the gynecological oncology patient group, there were 69 patients currently receiving modern medical treatments for cancer; among these patients, 58% reported using CAM; of these, 39.3% communicated their use of CAM to their physician. Patients in this group spent an average of $1,178 on CAM during their illness, with only 6.3% receiving insurance reimbursement. Benefits from CAM were perceived by 54.5% in this group. We concluded that cancer patients have a higher usage rate and expenditure for CAM, particularly while they are receiving medical therapy, and are more likely to discuss the use of alternative therapies with their physicians. CAM was perceived as helpful by patients despite the lack of scientific data about its effect.
Identifier
An unambiguous reference to the resource within a given context
<a href="http://doi.org/10.1046/j.1525-1438.2001.01011.x" target="_blank" rel="noreferrer noopener">10.1046/j.1525-1438.2001.01011.x</a>
Format
The file format, physical medium, or dimensions of the resource
Journal Article
2001
Cancer Patients
complementary and alternative medicines
gynecological oncology
GYNECOLOGY
Hopkins M P
International Journal of Gynecological Cancer
Jenison E L
Journal Article
Kirven M S
Obstetrics & Gynecology
oncology
Prevalence
Showalter A L
therapies
united-states
von Gruenigen V E
White L J
-
Text
A resource consisting primarily of words for reading. Examples include books, letters, dissertations, poems, newspapers, articles, archives of mailing lists. Note that facsimiles or images of texts are still of the genre Text.
URL Address
<a href="http://doi.org/10.1200/jco.2007.15.0235" target="_blank" rel="noreferrer noopener">http://doi.org/10.1200/jco.2007.15.0235</a>
Rights
Article information provided for research and reference use only. All rights are retained by the journal listed under publisher and/or the creator(s).
Pages
778-785
Issue
5
Volume
26
Search for Full-text
Locate full-text within NEOMED Library's e-journal collections
<p>Users with a NEOMED Library login can search for full-text journal articles at the following url: <a href="https://libraryguides.neomed.edu/home">https://libraryguides.neomed.edu/home</a></p>
Dublin Core
The Dublin Core metadata element set is common to all Omeka records, including items, files, and collections. For more information see, http://dublincore.org/documents/dces/.
Title
A name given to the resource
Preoperative chemotherapy: Updates of National Surgical Adjuvant Breast and Bowel Project Protocols B-18 and B-27
Publisher
An entity responsible for making the resource available
Journal of Clinical Oncology
Date
A point or period of time associated with an event in the lifecycle of the resource
2008
2008-02
Subject
The topic of the resource
cancer patients; chemotherapy; competing risk; conservative treatment; estrogen-receptor status; expressing estrogen; induction; multimodal; neoadjuvant chemotherapy; Oncology; radiation-therapy; treatment; tumor response
Creator
An entity primarily responsible for making the resource
Rastogi P; Anderson S J; Bear H D; Geyer C E; Kahlenberg M S; Robidoux A; Margolese R G; Hoehn J L; Vogel V G; Dakhil S R; Tamkus D; King K M; Pajon E R; Wright M J; Robert J; Paik S; Mamounas E P; Wolmark N
Description
An account of the resource
Purpose National Surgical Adjuvant Breast and Bowel Project (NSABP) Protocol B-18 was designed to determine whether four cycles of doxorubicin and cyclophosphamide (AC) administered preoperatively improved breast cancer disease-free survival (DFS) and overall survival (OS) compared with AC administered postoperatively. Protocol B-27 was designed to determine the effect of adding docetaxel (T) to preoperative AC on tumor response rates, DFS, and OS. Patients and Methods Analyses were limited to eligible patients. In B-18, 751 patients were assigned to receive preoperative AC, and 742 patients were assigned to receive postoperative AC. In B-27, 784 patients were assigned to receive preoperative AC followed by surgery, 783 patients were assigned to AC followed by T and surgery, and 777 patients were assigned to AC followed by surgery and then T. Results Results from B-18 show no statistically significant differences in DFS and OS between the two groups. However, there were trends in favor of preoperative chemotherapy for DFS and OS in women less than 50 years old (hazard ratio [HR] = 0.85, P = .09 for DFS; HR = 0.81, P = .06 for OS). DFS conditional on being event free for 5 years also demonstrated a strong trend in favor of the preoperative group (HR = 0.81, P = .053). Protocol B-27 results demonstrated that the addition of T to AC did not significantly impact DFS or OS. Preoperative T added to AC significantly increased the proportion of patients having pathologic complete responses (pCRs) compared with preoperative AC alone (26% v 13%, respectively; P < .0001). In both studies, patients who achieved a pCR continue to have significantly superior DFS and OS outcomes compared with patients who did not. Conclusion B-18 and B-27 demonstrate that preoperative therapy is equivalent to adjuvant therapy. B-27 also showed that the addition of preoperative taxanes to AC improves response.
Identifier
An unambiguous reference to the resource within a given context
<a href="http://doi.org/10.1200/jco.2007.15.0235" target="_blank" rel="noreferrer noopener">10.1200/jco.2007.15.0235</a>
Format
The file format, physical medium, or dimensions of the resource
Journal Article
2008
Anderson S J
Bear H D
Cancer Patients
Chemotherapy
competing risk
conservative treatment
Dakhil S R
estrogen-receptor status
expressing estrogen
Geyer C E
Hoehn J L
induction
Journal Article
Journal of Clinical Oncology
Kahlenberg M S
King K M
Mamounas E P
Margolese R G
multimodal
neoadjuvant chemotherapy
oncology
Paik S
Pajon E R
radiation-therapy
Rastogi P
Robert J
Robidoux A
Tamkus D
Treatment
tumor response
Vogel V G
Wolmark N
Wright M J
-
Text
A resource consisting primarily of words for reading. Examples include books, letters, dissertations, poems, newspapers, articles, archives of mailing lists. Note that facsimiles or images of texts are still of the genre Text.
Pages
4–20
Volume
17
Dublin Core
The Dublin Core metadata element set is common to all Omeka records, including items, files, and collections. For more information see, http://dublincore.org/documents/dces/.
Title
A name given to the resource
From mechanisms to management: translating the neuropathic pain consensus recommendations into clinical practice.
Publisher
An entity responsible for making the resource available
Journal of the American Academy of Nurse Practitioners
Date
A point or period of time associated with an event in the lifecycle of the resource
2005
2005-06-02
Subject
The topic of the resource
Adult; Female; Aged; Inflammation; Pain Measurement; Comorbidity; Education; Neoplasm Metastasis; Drugs; Perception; Clinical Trials; Middle Age; Sarcoidosis; Analgesics; Drug Therapy; Combination; Antidepressive Agents; Treatment Outcomes; Cancer Patients; Chronic Pain; Treatment Duration; Breast Neoplasms; Visual Analog Scaling; Lung Neoplasms; Melanoma; Rectal Neoplasms; Continuing (Credit); Transdermal Patches; Lidocaine – Administration and Dosage; Analgesics – Administration and Dosage; Analgesics – Adverse Effects; Cytokines – Physiology; Gabapentin – Administration and Dosage; Neural Transmission – Physiology; Neuralgia – Classification; Neuralgia – Drug Therapy; Neuralgia – Physiopathology; Opioid – Administration and Dosage; Peripheral Nervous System – Physiopathology; Tramadol – Administration and Dosage; Tricyclic – Administration and Dosage
Creator
An entity primarily responsible for making the resource
Chevlen E; Davies PS; Rhiner M
Description
An account of the resource
Chronic neuropathic pain poses a treatment challenge, and is associated with significant psychologic distress, physical disability, and impaired functioning, which impact the activities of daily living. Efforts to provide relief are often inadequate and/or require polypharmacy. This has spurred interest among researchers and clinicians alike to develop early, intensive treatments that target the molecular and cellular mechanisms involved in pain transduction, transmission, and modulation, or ideally, that prevent neuropathic pain from occurring in the first place. Currently, researchers are attempting to capitalize on our understanding of neuropathic pain pathophysiology to develop drugs that interrupt distinct activities involved in its perpetuation. In this regard, several potential agents (eg, NMDA and AMPA/kainate antagonists) are in phase 2 and 3 clinical trials. In the interim, evolving data and evidence-based neuropathic treatment recommendations provide guidance for selecting first- and second-line medications that alone or in combination offer acceptable neuropathic pain control and allow clinicians to bridge the gap between current knowledge and its application in the clinical setting. Hopefully, as basic and clinical science progresses, further treatment advances and management tools will be found to improve the care of patients who live with neuropathic pain.
Rights
Information about rights held in and over the resource
Article information provided for research and reference use only. All rights are retained by the journal listed under publisher and/or the creator(s).
2005
Adult
Aged
Analgesics
Analgesics – Administration and Dosage
Analgesics – Adverse Effects
Antidepressive Agents
Breast Neoplasms
Cancer Patients
Chevlen E
Chronic pain
Clinical Trials
Combination
Comorbidity
Continuing (Credit)
Cytokines – Physiology
Davies PS
Department of Internal Medicine
Drug Therapy
Drugs
Education
Female
Gabapentin – Administration and Dosage
Inflammation
Journal of the American Academy of Nurse Practitioners
Lidocaine – Administration and Dosage
Lung Neoplasms
Melanoma
Middle Age
NEOMED College of Medicine
Neoplasm Metastasis
Neural Transmission – Physiology
Neuralgia – Classification
Neuralgia – Drug Therapy
Neuralgia – Physiopathology
Opioid – Administration and Dosage
Pain Measurement
Perception
Peripheral Nervous System – Physiopathology
Rectal Neoplasms
Rhiner M
Sarcoidosis
Tramadol – Administration and Dosage
Transdermal Patches
Treatment Duration
Treatment Outcomes
Tricyclic – Administration and Dosage
Visual Analog Scaling
-
Text
A resource consisting primarily of words for reading. Examples include books, letters, dissertations, poems, newspapers, articles, archives of mailing lists. Note that facsimiles or images of texts are still of the genre Text.
URL Address
<a href="http://doi.org/10.1177/1078155210384301" target="_blank" rel="noreferrer noopener">http://doi.org/10.1177/1078155210384301</a>
Pages
403–408
Issue
4
Volume
17
Dublin Core
The Dublin Core metadata element set is common to all Omeka records, including items, files, and collections. For more information see, http://dublincore.org/documents/dces/.
Title
A name given to the resource
Potential for drug–drug interactions in treating cancer-related nausea and distress...[corrected] [published erratum appears in J ONCOL PHARM PRACT 2012; 18(1):160]
Publisher
An entity responsible for making the resource available
Journal of Oncology Pharmacy Practice
Date
A point or period of time associated with an event in the lifecycle of the resource
2011
2011-12
Subject
The topic of the resource
Drug Interactions; Chemotherapy; Cancer Patients; Drug Incompatibility; Drug Toxicity – Risk Factors; Antidepressive Agents – Contraindications; Antiemetics – Contraindications; Antiemetics – Therapeutic Use; Antipsychotic Agents – Contraindications; Cancer – Adverse Effects; Metoclopramide – Contraindications; Nausea and Vomiting – Chemically Induced; Nausea and Vomiting – Drug Therapy
Creator
An entity primarily responsible for making the resource
Saylor Matthew S; Smetana Ronald F
Identifier
An unambiguous reference to the resource within a given context
<a href="http://doi.org/10.1177/1078155210384301" target="_blank" rel="noreferrer noopener">10.1177/1078155210384301</a>
Rights
Information about rights held in and over the resource
Article information provided for research and reference use only. All rights are retained by the journal listed under publisher and/or the creator(s).
2011
Antidepressive Agents – Contraindications
Antiemetics – Contraindications
Antiemetics – Therapeutic Use
Antipsychotic Agents – Contraindications
Cancer – Adverse Effects
Cancer Patients
Chemotherapy
Drug Incompatibility
Drug Interactions
Drug Toxicity – Risk Factors
Journal of Oncology Pharmacy Practice
Metoclopramide – Contraindications
Nausea and Vomiting – Chemically Induced
Nausea and Vomiting – Drug Therapy
Saylor Matthew S
Smetana Ronald F
-
Text
A resource consisting primarily of words for reading. Examples include books, letters, dissertations, poems, newspapers, articles, archives of mailing lists. Note that facsimiles or images of texts are still of the genre Text.
Pages
25–27
Issue
3
Volume
33
Dublin Core
The Dublin Core metadata element set is common to all Omeka records, including items, files, and collections. For more information see, http://dublincore.org/documents/dces/.
Title
A name given to the resource
Fidaxomicin More Effective than Vancomycin for Clostridium difficile Infection in Cancer Patients?
Publisher
An entity responsible for making the resource available
Infectious Disease Alert
Date
A point or period of time associated with an event in the lifecycle of the resource
2013
2013-12
Subject
The topic of the resource
Cancer Patients; Randomized Controlled Trials; Double-Blind Studies; Vancomycin – Therapeutic Use; Clostridium Infections – Drug Therapy; Confidence Intervals – Utilization; Odds Ratio – Utilization; Fidaxomicin – Therapeutic Use; Recurrence – Prevention and Control
Creator
An entity primarily responsible for making the resource
Watkins Richard R
Rights
Information about rights held in and over the resource
Article information provided for research and reference use only. All rights are retained by the journal listed under publisher and/or the creator(s).
2013
Cancer Patients
Clostridium Infections – Drug Therapy
Confidence Intervals – Utilization
Department of Internal Medicine
Double-Blind Studies
Fidaxomicin – Therapeutic Use
Infectious Disease Alert
NEOMED College of Medicine
Odds Ratio – Utilization
RANDOMIZED controlled trials
Recurrence – Prevention and Control
Vancomycin – Therapeutic Use
Watkins Richard R
-
Text
A resource consisting primarily of words for reading. Examples include books, letters, dissertations, poems, newspapers, articles, archives of mailing lists. Note that facsimiles or images of texts are still of the genre Text.
URL Address
<a href="http://doi.org/10.1007/s11136-017-1745-8" target="_blank" rel="noreferrer noopener">http://doi.org/10.1007/s11136-017-1745-8</a>
Pages
1089–1098
Issue
4
Volume
27
Dublin Core
The Dublin Core metadata element set is common to all Omeka records, including items, files, and collections. For more information see, http://dublincore.org/documents/dces/.
Title
A name given to the resource
Minimal clinically important differences in the EORTC QLQ-C30 and brief pain inventory in patients undergoing re-irradiation for painful bone metastases.
Publisher
An entity responsible for making the resource available
Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation
Date
A point or period of time associated with an event in the lifecycle of the resource
2018
2018-04
Subject
The topic of the resource
*Bone metastases; *Brief pain inventory; *EORTC QLQ-C30; *Minimal Clinically Important Difference; *Minimal clinically important differences; *Radiation; 80 and over; 80 and Over; Adolescence; Adolescent; Adult; Aged; Bone Metastases – Radiotherapy; BONE metastasis; BONE metastasis – Treatment; Bone Neoplasms/*complications/radiotherapy/secondary; Brief Pain Inventory; BRIEF Pain Inventory; Cancer Patients; CANCER patients; CANCER radiotherapy; Clinical Assessment Tools; Female; Funding Source; Human; Humans; Instrument Scaling; LONGITUDINAL method; Male; Middle Age; Middle Aged; Pain Management; PAIN management; Pain/*diagnosis; Prospective Studies; Quality of Life/*psychology; Questionnaires; QUESTIONNAIRES; RANDOMIZED controlled trials; Re-Irradiation/*adverse effects; REOPERATION; Repeat Procedures; RESEARCH funding; SCALING (Social sciences); Secondary Analysis; SECONDARY analysis; Surveys and Questionnaires; Young Adult
Creator
An entity primarily responsible for making the resource
Raman Srinivas; Ding Keyue; Chow Edward; Meyer Ralph M; van der Linden Yvette M; Roos Daniel; Hartsell William F; Hoskin Peter; Wu Jackson S Y; Nabid Abdenour; Haas Rick; Wiggenraad Ruud; Babington Scott; Demas William F; Wilson Carolyn F; Wong Rebecca K S; Zhu Liting; Brundage Michael
Description
An account of the resource
PURPOSE: The EORTC QLQ-C30 and the Brief Pain Inventory (BPI) are validated tools for measuring quality of life (QOL) and the impact of pain in patients with advanced cancer. Interpretation of these instrument scores can be challenging and it is difficult to know what numerical changes translate to clinically significant impact in patients' lives. To address this issue, our study sought to establish the minimal clinically important differences (MCID) for these two instruments in a prospective cohort of patients with advanced cancer and painful bone metastases. METHODS: Both anchor-based and distribution-based methods were used to estimate the MCID scores from patients enrolled in a randomized phase III trial evaluating two different re-irradiation treatment schedules. For the anchor-based method, the global QOL item from the QLQ-C30 was chosen as the anchor. Spearman correlation coefficients were calculated for all items and only those items with moderate or better correlation (\textbarr\textbar \textgreater/= 0.30) with the anchor were used for subsequent analysis. A 10-point difference in the global QOL score was used to classify improvement and deterioration, and the MCID scores were calculated for each of these categories. These results were compared with scores obtained by the distribution-method, which estimates the MCID purely from the statistical characteristics of the sample population. RESULTS: A total of 375 patients were included in this study with documented pain responses and completed QOL questionnaires at 2 months. 9/14 items in the QLQ-C30 and 6/10 items in the BPI were found to have moderate or better correlation with the anchor. For deterioration, statistically significant MCID scores were found in all items of the QLQ-C30 and BPI. For improvement, statistically significant MCID scores were found in 7/9 items of the QLQ-C30 and 2/6 items of the BPI. The MCID scores for deterioration were uniformly higher than the MCIDs for improvement. Using the distribution-based method, there was good agreement between the 0.5 standard deviation (SD) values and anchor-based scores for deterioration. For improvement, there was less agreement and the anchor-based scores were lower than the 0.5 SD values obtained from the distribution-based method. CONCLUSION: We present MCID scores for the QLQ-C30 and BPI instruments obtained from a large cohort of patients with advanced cancer undergoing re-irradiation for painful bone metastases. The results from this study were compared to other similar studies which showed larger MCID scores for improvement compared to deterioration. We hypothesize that disease trajectory and patient expectations are important factors in understanding the contrasting results. The results of this study can guide clinicians and researchers in the interpretation of these instruments.
Identifier
An unambiguous reference to the resource within a given context
<a href="http://doi.org/10.1007/s11136-017-1745-8" target="_blank" rel="noreferrer noopener">10.1007/s11136-017-1745-8</a>
Rights
Information about rights held in and over the resource
Article information provided for research and reference use only. All rights are retained by the journal listed under publisher and/or the creator(s).
*Bone metastases
*Brief pain inventory
*EORTC QLQ-C30
*Minimal Clinically Important Difference
*Minimal clinically important differences
*Radiation
2018
80 and over
Adolescence
Adolescent
Adult
Aged
Babington Scott
Bone Metastases – Radiotherapy
BONE metastasis
BONE metastasis – Treatment
Bone Neoplasms/*complications/radiotherapy/secondary
Brief pain inventory
Brundage Michael
Cancer Patients
CANCER radiotherapy
Chow Edward
Clinical Assessment Tools
Demas William F
Ding Keyue
Female
Funding Source
Haas Rick
Hartsell William F
Hoskin Peter
Human
Humans
Instrument Scaling
LONGITUDINAL method
Male
Meyer Ralph M
Middle Age
Middle Aged
Nabid Abdenour
Pain Management
Pain/*diagnosis
Prospective Studies
Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation
Quality of Life/*psychology
Questionnaires
Raman Srinivas
RANDOMIZED controlled trials
Re-Irradiation/*adverse effects
Reoperation
Repeat Procedures
RESEARCH funding
Roos Daniel
SCALING (Social sciences)
Secondary Analysis
Surveys and Questionnaires
van der Linden Yvette M
Wiggenraad Ruud
Wilson Carolyn F
Wong Rebecca K S
Wu Jackson S Y
Young Adult
Zhu Liting